Growth Metrics

Innoviva (INVA) EPS (Basic) (2016 - 2025)

Innoviva (INVA) has disclosed EPS (Basic) for 16 consecutive years, with $1.65 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Basic) rose 8150.0% year-over-year to $1.65, compared with a TTM value of $1.94 through Sep 2025, up 5.43%, and an annual FY2025 reading of $4.02, up 986.49% over the prior year.
  • EPS (Basic) was $1.65 for Q3 2025 at Innoviva, up from $1.01 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $3.81 in Q3 2022 and bottomed at -$0.74 in Q1 2025.
  • Average EPS (Basic) over 5 years is $0.88, with a median of $0.58 recorded in 2024.
  • The sharpest move saw EPS (Basic) plummeted 1933.33% in 2024, then soared 8150.0% in 2025.
  • Year by year, EPS (Basic) stood at $2.96 in 2021, then increased by 28.72% to $3.81 in 2022, then tumbled by 53.02% to $1.79 in 2023, then crashed by 98.88% to $0.02 in 2024, then skyrocketed by 8150.0% to $1.65 in 2025.
  • Business Quant data shows EPS (Basic) for INVA at $1.65 in Q3 2025, $1.01 in Q2 2025, and -$0.74 in Q1 2025.